Roll No. ____________________ Total No. of Pages : 01
Total No. of Questions : 06
M.Pharmacy (Pharmacology) (Sem.-2)
--- Content provided by FirstRanker.com ---
CLINICAL RESEARCH & PHARMACOVIGILANCE
Subject Code : MPL-204T
M.Code : 74946
Time : 3 Hrs. Max. Marks: 75
INSTRUCTIONS TO CANDIDATES :
--- Content provided by FirstRanker.com ---
- Attempt any FIVE questions out of SIX questions.
- Each question carries FIFTEEN marks.
- a) Outline the requirements for a sterile product manufacturing plant. Indicate various areas with the help of an illustration. (7.5)
b) Describe the constitution of IRB. Mention the functions of IRB. (7.5) - a) Write a note on cross sectional observation studies. (7.5)
--- Content provided by FirstRanker.com ---
b) Comment on the responsibilities of study coordinator of a clinical trial. (7.5) - a) What is an investigator brochure? Outline the contents of this brochure and mention the purpose of each entry in the form. (7.5)
b) What is ADR? Give five examples of ADRs. How are ADRs detected and reported? Outline the format used for this purpose. (7.5) - Outline the importance of safety monitoring in clinical trials. Give a detailed account of safety monitoring in clinical trials. (15)
- Give a detailed account of passive and active surveillance in pharmacovigilance. Outline the steps involved in each. (15)
- Write notes on (any three) : (5 x 3 = 15)
- Pharmacoeconomics
- Responsibilities of a CRO
- Pharmacovigilance in hospitals
- International classification of diseases
--- Content provided by FirstRanker.com ---
--- Content provided by FirstRanker.com ---
NOTE : Disclosure of Identity by writing Mobile No. or Making of passing request on any page of Answer Sheet will lead to UMC against the Student.
1| M-74946 (531)-2510
--- Content provided by FirstRanker.com ---
This download link is referred from the post: PTU M.Pharm 2020 March Previous Question Papers